Elvira Rubio Esparza, MD

Risk management and communication unit
Pharmacoepidemiology and Pharmacovigilance Division. Medicines for Human Use Department. Spanish Agency for Medicines and Medical Devices (AEMPS), Spain

Poster(s):

• (024) Impact of regulatory interventions on immediate release fentanyl and alternatives use in Spain: an interrupted time-series analysis
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST